Janus Henderson Investors US’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | $28.7M | Sell |
434,083
-1,885
| -0.4% | -$124K | 0.02% | 545 |
|
2016
Q4 | $27.6M | Buy |
435,968
+103,051
| +31% | +$6.53M | 0.02% | 559 |
|
2016
Q3 | $21.2M | Sell |
332,917
-60
| -0% | -$3.82K | 0.02% | 578 |
|
2016
Q2 | $24.8M | Buy |
332,977
+4,689
| +1% | +$349K | 0.02% | 538 |
|
2016
Q1 | $21.9M | Sell |
328,288
-3,876
| -1% | -$259K | 0.02% | 569 |
|
2015
Q4 | $22.5M | Sell |
332,164
-47,808
| -13% | -$3.23M | 0.02% | 584 |
|
2015
Q3 | $20.3M | Buy |
379,972
+58,958
| +18% | +$3.15M | 0.02% | 606 |
|
2015
Q2 | $20.2M | Buy |
321,014
+197,423
| +160% | +$12.4M | 0.02% | 602 |
|
2015
Q1 | $5.95M | Buy |
+123,591
| New | +$5.95M | ﹤0.01% | 768 |
|